biomarkers to predict the sensitivity and response of ck2 protein kinase mediated diseases to ck2 inhibitors

摘要

biomarkers to predict the sensitivity and response of ck2 protein kinase mediated diseases to ck2 inhibitors. biomarkers are disclosed for determining the sensitivity of ck2 protein kinase mediated diseases, such as inflammatory and / or proloferative disorders, to treatment with ck2 inhibitors. These biomarkers can be used to predict or select individuals who are likely to be responsive to ck2 inhibitor treatment and to treat or monitor individuals undergoing ck2 inhibitor treatment.